Zkusit zdarma
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

ANIP
Cena:
 
 
Valuace
48
Růst
86
Zdraví
68

Výsledky Q1 2026

Načítám obsah…
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations.
The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
preloader

Prezentace a earnings calls ANI Pharmaceuticals, Inc. (ANIP)

DatumNázevKvartálRok
08.05.2026ANIP Q1 2026Q12026
03.03.2026ANIP Corporate presentation--
27.02.2026ANIP Q4 2025Q42025
12.01.2026ANIP Corporate presentation--
23.07.2025ANIP Study Update--
03.06.2025ANIP Corporate Presentation--
05.02.2025ANIP Guggenheim SMID Cap Biotech Conference--
14.01.2025ANIP 43rd Annual J.P. Morgan Healthcare Conference 2025--
24.06.2024ANIP M&A Announcement--
12.09.2023ANIP Investor Presentation--